| TalkMarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
JMP Reiterates $191 Price Target On Esperion After Japan Partnership
Article By: The Fly
Monday, April 20, 2020 1:16 PM EST
JMP Securities analyst Jason Butler reiterates an "Outperform" rating on Esperion Therapeutics, with a $191 price target after the company announced a Japanese partnership with Otsuka, for its bempedoic acid franchise.
In this article: ESPR, OTSKY

Latest Tweets for $OTSKY

No tweets yet!